Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


123>>>
52 Items
Title  Creator  Group name  Publishing year 
[Preventing the risks of interaction between cancer treatments and complementary care strategies] Ninot et al. EquipeAD 2024-11-15
[Drosophila as a model to study cancer biology] Falconi et al. EquipeAD 2024-09
The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells Slaninová et al. EquipeAD 2024-05-14
Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study Nicolle et al. EquipeAD 2024-10-08
Head and neck cancer patients treated with concomitant chemoradiotherapy involving the oral cavity and oropharynx: is another choice possible than prophylactic gastrostomy? Senesse et al. EquipeAD 2024-05-01
Fat body glycolysis defects inhibit mTOR and promote distant muscle disorganization through TNF-?/egr and ImpL2 signaling in Drosophila larvae Rodríguez-Vázquez et al. EquipeAD 2024-09-09
Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy Faravel et al. EquipeAD 2023
Response to Somay et al. Letter to the Editor Regarding "Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy" Faravel et al. EquipeAD 2023
Identification of 18F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer Galvez et al. EquipeAD 2023-07-05
Factitious hypoglycemia in insulin-treated diabetic patients Galvez et al. EquipeAD 2023-05
Accurate selection of insulin immunoassay to discern factitious hypoglycemia: a case report Lotierzo et al. EquipeAD 2023-02
Mechanisms underlying the cooperation between loss of epithelial polarity and Notch signaling during neoplastic growth in Drosophila Logeay et al. EquipeAD 2022-01-10
Reply to Caccialanza et al Boisselier et al. EquipeAD 2021-04-06
Paracrine Behaviors Arbitrate Parasite-Like Interactions Between Tumor Subclones Noble et al. EquipeAD 2021-07
Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy? Lognos et al. EquipeAD 2021-10-28
Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1 Ordas et al. EquipeAD 2021-06-18
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis Kantar et al. EquipeAD 2021-03-11
Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility Study Faravel et al. EquipeAD 2021 Jan-Dec
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis Martin et al. EquipeAD 2021-10
[Not Available] Lacroix et al. EquipeAD 2020
Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes Frere et al. EquipeAD 2020-04
Exercise and cancer: Evidence of efficacy during and after treatments Ninot et al. EquipeAD 2020-04
Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients Martin et al. EquipeAD 2020-02
Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial Jacot et al. EquipeAD Oct 09, 2020
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX Boisselier et al. EquipeAD Sep 16, 2020
123>>>
52 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés